<SEC-DOCUMENT>0001179110-20-005828.txt : 20200512
<SEC-HEADER>0001179110-20-005828.hdr.sgml : 20200512
<ACCEPTANCE-DATETIME>20200512174344
ACCESSION NUMBER:		0001179110-20-005828
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200508
FILED AS OF DATE:		20200512
DATE AS OF CHANGE:		20200512

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Strom Carrie C
		CENTRAL INDEX KEY:			0001811896

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35565
		FILM NUMBER:		20870338

	MAIL ADDRESS:	
		STREET 1:		1 N. WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbbVie Inc.
		CENTRAL INDEX KEY:			0001551152
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				320375147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		(847) 932-7900

	MAIL ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 3 -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-05-08</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001551152</issuerCik>
        <issuerName>AbbVie Inc.</issuerName>
        <issuerTradingSymbol>ABBV</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001811896</rptOwnerCik>
            <rptOwnerName>Strom Carrie C</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1 N. WAUKEGAN ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NORTH CHICAGO</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>SVP &amp; Pres Global Allerg Aesth</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, $0.01 par value</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes></footnotes>

    <ownerSignature>
        <signatureName>Steven L. Scrogham, attorney-in-fact for Carrie Strom</signatureName>
        <signatureDate>2020-05-12</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>cstrompoa.txt
<DESCRIPTION>POA
<TEXT>
POWER OF ATTORNEY


The undersigned constitutes and appoints LAURA J. SCHUMACHER,
JENNIFER M. LAGUNAS, STEVEN L. SCROGHAM, and EMILY A. WEITH,
and each of them individually, as the undersigned's true and
lawful attorney-in-fact and agent, with full power of
substitution and re-substitution, for the undersigned and in
the undersigned's name, place and stead, to prepare and sign
any and all Securities and Exchange Commission ("SEC") Notices
of Proposed Sales of Securities pursuant to Rule 144 under the
Securities Act of 1933 on Form 144, all SEC statements on Forms
3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other
documents necessary to obtain codes and passwords necessary to
make electronic filings, and any amendments or successors to
such forms, and to file the same with all exhibits thereto,
and other documents in connection therewith, with the SEC,
granting unto said attorney-in-fact and agent full power and
authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and
Section 16(a), as fully for all intents and purposes as the
undersigned might or could do in person, hereby ratifying and
confirming all that said attorney-in-fact and agent may lawfully
do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC.
The authorization set forth above shall continue in full force and
effect until the undersigned is no longer required to file Forms
144, 3, 4, or 5 or if earlier, until the undersigned revokes
such authorization by written instructions to the
attorney-in-fact.



Date:  February 16,2020

/s/ Carrie Strom
Signature of Reporting Person

Thomas Hudson
Name


AbbVie Inc.
1 N. Waukegan Road
North Chicago, IL   60064

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
